| PACKAGING TYPE: | 10x10 Tablets In C-box |
| COMPOSITION: | Rasagiline Tablets 0.5 Mg |
| FORMULATION: | Tablets |
| Description: | RELTAFER 0.5 Tablet contains Rasagiline 0.5 mg, an anti-Parkinson medication used as monotherapy or in combination with other Parkinson’s treatments. It helps increase and maintain dopamine activity in the brain, thereby improving motor symptoms and enhancing daily functioning. The medication is widely used in the long-term management of Parkinson’s disease under specialist supervision. |
| Side Effects: | Headache Dizziness Joint pain Nausea Insomnia |
| How to Use: | Take as prescribed by the neurologist Swallow with water Can be taken with or without food Follow the prescribed dosage schedule regularly |
| Precaution: | Use under strict medical supervision Inform the doctor about all ongoing medications Avoid exceeding the recommended dose Monitor for unusual mood or behavioral changes Store in a cool and dry place away from direct sunlight |
| Product Benefits: | Helps manage symptoms of Parkinson’s disease Improves motor function and mobility Supports dopamine activity in the brain Helps reduce stiffness and movement difficulties Suitable for long-term neurological care |
| Expiry Date: | 2028-03-31 |
Frequently Asked Questions
RELTAFER 0.5 Tablet is used in the treatment of Parkinson’s disease to help improve movement control and manage symptoms such as stiffness, tremors, and slowed movements.
It contains Rasagiline 0.5 mg, a selective monoamine oxidase-B (MAO-B) inhibitor.
Rasagiline works by increasing dopamine levels in the brain through inhibition of the MAO-B enzyme, helping improve motor function in patients with Parkinson’s disease.










